Venetoclax synergizes with gilteritinib in FLT3 wild-type high-risk acute myeloid leukemia by suppressing MCL-1Maike Janssen, Sascha Dietrich, Christina Schmidt et al.|Blood|2022Cited by 100
Proteogenomics refines the molecular classification of chronic lymphocytic leukemiaSophie A. Herbst, Sascha Dietrich, Berit J. Brinkmann et al.|Nature Communications|2022Cited by 42
Comparing the value of mono- vs coculture for high-throughput compound screening in hematological malignanciesSophie A. Herbst, Sascha Dietrich|Blood Advances|2023Cited by 10
Decrypting the potency of anti-cancer therapeutics by using mass spectrometry to quantify post-translational modificationsSophie A. Herbst, Forest M. White|Cell Reports Methods|2023Cited by 2